Skip to content
Peptideworth

Provider review

Idgie Health review: pharmacy disclosure, fees and cancellation questions

Idgie now publishes more practical information than it did when we first reviewed it: a named pharmacy partner, a no-membership-fee homepage claim and a prescription return policy. Those disclosures help a buyer ask more precise questions. Confirm the pharmacy assigned to your order, the full recurring charge and the cutoff for stopping the next shipment.

By Grant Delaney, Research EditorUpdated

Some links on this site are affiliate links, and we may earn a commission. How we’re paid

Visit Idgie Health

Of Idgie Health’s 2 dated product claims documented below, 2 are consistent with the cited evidence. Among the dated prices documented below, the lowest listed upfront charge is $149 for 30 days (Compounded semaglutide injection, billed monthly). A matching claim does not mean the compounded product was tested or FDA-approved.

The current site answers more pharmacy and service questions; clarify the actual order terms before relying on general no-fee or pause-anytime claims.

Worth trusting if

  • You want a publicly named pharmacy partner
  • You prefer to confirm a specific product quote and renewal schedule before enrolling

Be skeptical if

  • You need a guaranteed product-by-state eligibility list
  • You require an unconditional refund after dispensing

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

Reviewed

Compounded

Evidence

Phase 3 trials

Pharmacy

Named

FDA letter

None found

Provenance

Products reviewed at Idgie Health

These evidence cards classify the treatments evaluated in this review. Confirm the exact medicine and formulation proposed for your prescription with the care team.

Compounded (503A)2 products

Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

  • Compounded semaglutide injection — $149 a month; the advertised $114 needs six months paid up front.
  • Compounded tirzepatide injection — $229 a month; the advertised $171 needs six months up front.

Evidence

Has the molecule been tested for what it is sold for?

Each row summarizes human evidence for the molecule and the use being advertised. Results apply to the product, dose, population and outcome studied; they do not establish that this provider’s preparation or program produces the same results. Compounded drugs are not FDA-approved. Evidence for one use should not be assumed to support another.

Semaglutide · compounded
Phase 3 trials
Tirzepatide · compounded
Phase 3 trials

2

Products with human evidence

For the advertised use, out of 2 products reviewed here. The evidence concerns the molecule, not Idgie Health's service.

2

Registry records cited

Distinct ClinicalTrials.gov records cited across the reviewed products. Registration alone does not establish that a treatment works.

The comparison

What they claim, against what the trials show

Each claim below is quoted word for word from Idgie Health’s own page. Tap a row to see the quote, the trials behind it, and why it got that verdict.

Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“Less hunger. Steady progress. 1 Month · Billed monthly · all doses. Licensed provider oversight. Free discreet shipping. Pause or cancel.”

Read on the Idgie Health site, September 2026

Phase 3 trials

What the trials show for Semaglutide

  • NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg, mean weight reduction of about 15%. Listed as the molecule's evidence base; Idgie cites no trial anywhere on its site.

"Less hunger. Steady progress" is about as small a claim as a seller can make and still be selling something. It names an effect the molecule genuinely has — appetite suppression is the mechanism, not a side benefit — and attaches no number, no timeline and no rate to it. There is nothing here for STEP 1 to contradict. The one claim worth crediting sits on the plan rather than in the marketing: "all doses" is printed on the monthly tier itself, which is the right place for a flat-price promise, because a promise attached to the thing you buy is harder to quietly drop than one in a banner.1

Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“One weekly dose. 1 Month · Billed monthly, flexible. Licensed provider oversight. Free discreet shipping. Pause or cancel.”

Read on the Idgie Health site, September 2026

Phase 3 trials

What the trials show for Tirzepatide

  • NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly. Again the molecule's evidence base rather than a citation Idgie makes.

"One weekly dose" is the entire claim, and it is accurate — tirzepatide is a once-weekly injection. Nothing about weight, rate or outcome appears on the page. Worth noting what is missing rather than wrong: the flat-price wording that sits on the semaglutide plan does not appear on any tirzepatide tier, which are labeled monthly and flexible instead. So the promise that the price holds at every dose is demonstrable for one of Idgie's two drugs and not the other, and the site never addresses the difference.2

Dispensing chain

Who actually fills your prescription

Pharmacy named
  • VialsRX
Read the full account

The October 13 partner-pharmacy page names VialsRX, 6220 Westpark Dr, Houston, TX 77057, telephone 713-497-5590. Confirm the assigned pharmacy and state-specific fulfillment for the actual prescription.

Read on the Idgie Health site, October 2026.

Quality

Third-party testing, and what is published

—

Describes a testing regime

Not established in this source review

—

Certificate of analysis readable

A readable lot report was not verified here

Read the full testing account

The September source check did not verify a public batch certificate. This does not establish that the pharmacy performs no testing. The October homepage says no membership fee; the earlier membership ambiguity is discussed in the current review.

Read on the Idgie Health site, September 2026.

Licensing

Licensed to dispense, and where

Coverage

The current site claims services in all 50 states, while its pharmacy page explicitly says medication, formulation and fulfillment options can vary by state. Confirm the specific prescription before payment.

Read the full licensing claim

Idgie Health is a DBA of Feel Better Health Group, LLC. Its refund page now lists 821 N St., Suite 102, Anchorage, AK 99501; this is a published contact address, not independent corporate or license verification.

Read on the Idgie Health site, October 2026.

Regulatory

The FDA warning letter

No FDA warning letter found

None of the 113 warning letters FDA sent to telehealth companies in its September 2025, February 2026 and June 2026 enforcement waves names Idgie Health (Feel Better Health Group, LLC). Checked in September 2026; that covers those letters, not every action FDA has ever taken.

Assessment

What holds up, and what does not

What holds up
  • A dedicated page now names VialsRX and gives contact details.
  • The homepage states that no membership fee applies.
  • The site distinguishes clinical services from its platform role.
What does not
  • General nationwide service still has product-specific restrictions.
  • Prescription returns are restricted; pausing future orders does not reverse an existing order.
  • The terms and quote for the actual plan need to resolve older membership wording.

Verdict

The bottom line

Get a written plan total and cancellation cutoff. The current homepage says no membership fee, and a dedicated page now names VialsRX; our earlier absence claims are superseded. General nationwide service does not establish availability of every formulation in every state.

Visit Idgie Health

Opens Idgie Health's website. A link is not a recommendation to take anything.

A named pharmacy replaces an earlier gap

The partner-pharmacy page checked October 13 names VialsRX in Houston, with an address and telephone number. Our earlier statement that no individual pharmacy was named is superseded. Ask whether that pharmacy will fill your specific prescription, and verify its license for your state. The same page says medications, formulations and fulfillment options can vary by state. 3

This is a useful disclosure, not an independent assessment of a batch or a guarantee that every product is available everywhere. The homepage identifies 503A pharmacy services and distinguishes the platform from the clinicians and pharmacies providing treatment. 4

Full analysis — 3 more sectionsIs there a separate membership charge? · Pausing is different from refunding · What the clinical claims establish

Is there a separate membership charge?

The current homepage says there is no membership fee and that patients can pause their plan. Our September reading of the terms found language about a recurring membership payment. That older wording should no longer be presented as proof of an undisclosed extra charge. Ask which current terms govern your order and whether the displayed product price covers the clinician, medication and shipping. 4

A useful quote gives the total due now, supply length, next renewal date and dose-related price changes. Without those details, two monthly headlines may represent different commitments. Historical price captures below retain their original dates.

Pausing is different from refunding

The current refund page says prescription products cannot be returned for reuse or resale and that sales are final, with support available for a suspected filling error. It also publishes an Anchorage contact address. 5

Before a renewal, find out whether a pause takes effect before clinical review, pharmacy submission or shipping. The policy does not provide an unconditional refund for an order simply because you no longer want treatment. We have not tested intake or ordered medication.

What the clinical claims establish

Our original product-page check found restrained language about appetite rather than a quantified weight-loss promise. That does not establish outcomes for an individual compounded prescription. The prescription, formulation, monitoring plan and clinician’s advice matter more than the absence of a dramatic marketing number. STEP 1 provides context for the approved semaglutide product studied, not proof that every compounded preparation is equivalent. 1

Questions

Frequently asked questions

Which pharmacy does Idgie name?

The partner-pharmacy page checked October 13 names VialsRX in Houston. Confirm the pharmacy assigned to your prescription rather than assuming one listed partner fills every order.

Does Idgie charge membership?

The current homepage says no membership fee. Older terms used membership language; confirm the actual plan total rather than assuming a second fee exists.

Can I return medication after changing my mind?

The public refund policy says prescription products cannot be returned for reuse or resale and sales are final. Contact support for a suspected filling error and ask about the cutoff for pausing future orders.

Glossary

Key terms

Show definitions
Compounded
Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
Titration
Starting at a low dose and stepping up over weeks to a target. It's why a flat-price promise matters — the cost of a GLP-1 usually appears on the way up, not at the start.
STEP 1
The phase 3 trial of once-weekly semaglutide 2.4 mg for weight loss — 1,961 adults over 68 weeks, published in the New England Journal of Medicine in 2021.

Compare

Others selling what Idgie Health sells

Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.

Ranked

The lists Idgie Health is on

Method

How we checked this

Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.

Read our methodology

Claims read first-party

Every quoted claim was read off Idgie Health's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.

Trials read from the registry

Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.

Absence claims bounded

Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.

Letters matched on full name

FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.

Sources

References

Show all 5 sources
  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, mean weight reduction of about 15%. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
  3. Publisher (2026). Partner pharmacy information checked October 13. Public primary source. the Idgie Health site
  4. Publisher (2026). Idgie public care and fee statements checked October 13. Public primary source. the Idgie Health site
  5. Publisher (2026). Idgie refund policy checked October 13. Public primary source. the Idgie Health site

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.